The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| CL | -16.63% | +13.91% | +2.64% | +40,987% |
| S&P | +18.37% | +110.18% | +16.02% | +7,053% |
Colgate-Palmolive Co. is engaged in the manufacturing and distribution of consumer products. It operates through the Oral, Personal and Home Care, and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors. The Pet Nutrition segment offers pet nutrition products for dogs and cats. The company was founded by William Colgate in 1806 and is headquartered in New York, NY.
Get a list of current -- and potential future -- Dividend Kings and learn how to leverage these strong companies to build wealth.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $5.11B | 1.0% |
| Gross Profit | $3.07B | 0.0% |
| Gross Margin | 60.06% | -0.6% |
| Market Cap | $73.67B | -7.5% |
| Market Cap / Employee | $2.17M | 0.0% |
| Employees | 34K | 0.0% |
| Net Income | $773.00M | 0.8% |
| EBITDA | $1.27B | -3.7% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $1.22B | 9.5% |
| Accounts Receivable | $1.77B | -2.8% |
| Inventory | 2.1K | 10.3% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $7.14B | -12.3% |
| Short Term Debt | $1.61B | 204.5% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 17.14% | -0.2% |
| Return On Invested Capital | 27.53% | 1.3% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $776.00M | -11.1% |
| Operating Free Cash Flow | $884.00M | -10.7% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 29.82 | 25.89 | 26.53 | 25.55 | -9.42% |
| Price to Book | 689.63 | 170.75 | 359.14 | 202.94 | -41.37% |
| Price to Sales | 4.25 | 3.71 | 3.83 | 3.70 | -7.56% |
| Price to Tangible Book Value | -16.93 | -15.51 | -15.81 | -15.50 | -3.68% |
| Price to Free Cash Flow TTM | 47.73 | 38.71 | 41.64 | 42.59 | -6.28% |
| Enterprise Value to EBITDA | 73.59 | 66.32 | 67.60 | 64.47 | -3.25% |
| Free Cash Flow Yield | 2.1% | 2.6% | 2.4% | 2.3% | 6.71% |
| Return on Equity | 1346.9% | 704.0% | 977.1% | 705.2% | -92.67% |
| Total Debt | $8.44B | $8.51B | $8.27B | $8.76B | 0.95% |
CL earnings call for the period ending September 30, 2021.
CL earnings call for the period ending June 30, 2021.
CL earnings call for the period ending March 31, 2021.
CL earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
